Timothy R. Asmis - Concepedia

Author

Timothy R. Asmis

Also Known As

A Arnaout, T. Asmis, T. R. Asmis, T., Asmis, T.R. Asmis, TIMOTHY R. ASMIS, Timothy Asmis, Timothy R . Asmis, Timothy R. Asmis

117

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Ottawa Hospital University of Ottawa Memorial Sloan Kettering Cancer Center Sunnybrook Health Science Centre Princess Margaret Cancer Centre

About

Timothy R. Asmis is an author at Ottawa Hospital specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	995
2	Health Sciences	5	5	220
3	Cell Biology	2	2	140
4	Nursing	1	1	24
5	Social Sciences	1	1	24

Timothy R. Asmis

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
Ponsegromab for the Treatment of Cancer Cachexia John D. Groarke, Jeffrey Crawford, Susie M. Collins, New England Journal of Medicine	2024	186
Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease Michael M. Vickers, Jair Bar, Ivan Gorn‐Hondermann, Clinical & Experimental Metastasis Stage-dependent Differential ExpressionMedicineColorectal CancerPathologyPotential Role	2011	112
Overview of Systemic Therapy for Colorectal Cancer Rachel Goodwin, Timothy R. Asmis Clinics in Colon and Rectal Surgery Surgical OncologyGastrointestinal OncologyMedicineSystemic TreatmentPharmacology	2009	76
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement Paul J. Karanicolas, Peter Metrakos, Kelvin Chan, Current Oncology Surgical OncologyGastroenterologySurgeryPharmacotherapyMetronomic Chemotherapy	2013	75
Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo Michael M. Vickers, Erin Powell, Timothy R. Asmis, European Journal of Cancer Pancreatic CancerOverall SurvivalNcic Ctg Pa.3MedicineGastrointestinal Oncology	2011	68
An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer Rocio García‐Carbonero, Fernando Rivera, Joan Maurel, The Oncologist	2014	63
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation Shaan Dudani, Horia Marginean, Patricia A. Tang, BMC Cancer	2019	60
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial Derek J. Jonker, Patricia A. Tang, Hagen F. Kennecke, Clinical Colorectal Cancer OncologyGastrointestinal OncologyClinical TrialsPathologyColorectal Cancer	2018	55
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity Timothy R. Asmis, Ki Y. Chung, Jerrold B. Teitcher, Investigational New Drugs Pneumatosis IntestinalisMedicineGastroenterologyColorectal CancerPathology	2007	43

Page 1